Press Releases

Press Releases

March 25, 2020
Establishment Labs Receives Issuance for Key U.S. Patent Covering Company’s Implant Surface Technology
NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the U.S. Patent & Trademark Office has issued a patent protecting
March 16, 2020
Establishment Labs Reports Fourth Quarter and Full Year 2019 Financial Results
NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the fourth quarter and full year ended
March 3, 2020
Establishment Labs to Announce Fourth Quarter 2019 Financial Results on March 16
NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the
February 25, 2020
ESTA Announces Participation at the Cowen and Company 40th Annual Health Care Conference
NEW YORK, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced that CEO and Founder Juan José Chacón-Quirós will participate at the
February 3, 2020
Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
NEW YORK, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced the closing of its previously announced public
January 29, 2020
Establishment Labs Announces Pricing of Public Offering of Common Shares
NEW YORK, Jan. 29, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced the pricing of its public offering of 2,285,714 common
January 28, 2020
Establishment Labs Announces Preliminary Results for Fourth Quarter and Full Year 2019; Reports Record Revenue
NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced preliminary financial results for the fourth quarter and full year
January 28, 2020
Establishment Labs Announces Proposed Public Offering of Common Shares
NEW YORK, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – today announced that it has commenced a public offering of